An oversight committee Tuesday urged the bond-funded California Institute for Regenerative Medicine to improve its transparency and accountability. CIRM was created as part of a 2004 ballot measure that authorized $3 billion in state general obligation bonds to finance stem-cell medical research.

The institute’s citizens financial accountability oversight committee voted to approve a series of recommendations from the Little Hoover Commission, a state watchdog agency. Those recommendations call for CIRM to improve efficiency and transparency in the way grants and loans are distributed, and to make future business practices more open.

Subscribe Now

Independent and authoritative analysis and perspective for the bond buying industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.